Search
Search Results
##search.searchResults.foundPlural##
-
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2593PDF: 1061HTML: 100 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1358PDF: 805HTML: 3109 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3170PDF: 985HTML: 1996 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
980PDF: 837Suppl. Files: 450HTML: 275 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2657PDF: 987HTML: 2243 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1548PDF: 857HTML: 3146Figure 5: 149Figure 4: 150Figure 3: 184Figure 1: 162Figure 2: 157 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3829PDF: 1453HTML: 8500 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1577PDF: 776HTML: 1220Figure 1: 160Figure 2: 175Figure 3: 170 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
897PDF: 446HTML: 105 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1793PDF: 815HTML: 1564 -
Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
3276PDF: 568HTML: 640 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1347PDF: 1281HTML: 84 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1547PDF: 833HTML: 1025Picture 1: 156 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1542PDF: 953HTML: 174 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1780PDF: 781HTML: 3586 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4197PDF: 1154HTML: 2136Figure 1: 152 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
711PDF: 457HTML: 6254 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1396PDF: 1193HTML: 489 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4402PDF: 1894HTML: 17716 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7789PDF: 4054HTML: 7319 -
Seroprevalence of transfusion-transmissible infections among family replacement donors and voluntary non-remunerated blood donors during the COVID-19 pandemic in sub Saharan Africa family replacement donors and voluntary non-remunerated blood donors in transfusion transmissible infections
1525PDF: 1250HTML: 132 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1135PDF: 809HTML: 2166Figue 1: 164







